237 related articles for article (PubMed ID: 12506103)
21. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
22. Agents that bind annexin A2 suppress ocular neovascularization.
Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
[TBL] [Abstract][Full Text] [Related]
23. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model.
Ishida K; Yoshimura N; Mandai M; Honda Y
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1512-9. PubMed ID: 10359334
[TBL] [Abstract][Full Text] [Related]
25. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
[TBL] [Abstract][Full Text] [Related]
26. A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.
Zhang L; Shen X; Lu Q; Zhou Q; Gu J; Gan R; Zhang H; Sun X; Xie B
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):731-9. PubMed ID: 21881847
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
28. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
[TBL] [Abstract][Full Text] [Related]
29. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Lima e Silva R; Hylton D; Rudge JS; Wiegand SJ; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):241-8. PubMed ID: 12652651
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress promotes ocular neovascularization.
Dong A; Xie B; Shen J; Yoshida T; Yokoi K; Hackett SF; Campochiaro PA
J Cell Physiol; 2009 Jun; 219(3):544-52. PubMed ID: 19142872
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy.
Sennlaub F; Valamanesh F; Vazquez-Tello A; El-Asrar AM; Checchin D; Brault S; Gobeil F; Beauchamp MH; Mwaikambo B; Courtois Y; Geboes K; Varma DR; Lachapelle P; Ong H; Behar-Cohen F; Chemtob S
Circulation; 2003 Jul; 108(2):198-204. PubMed ID: 12821538
[TBL] [Abstract][Full Text] [Related]
32. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo.
Yoshida S; Amano H; Hayashi I; Kitasato H; Kamata M; Inukai M; Yoshimura H; Majima M
Lab Invest; 2003 Oct; 83(10):1385-94. PubMed ID: 14563940
[TBL] [Abstract][Full Text] [Related]
33. In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Walters T; Raizman M; Ernest P; Gayton J; Lehmann R
J Cataract Refract Surg; 2007 Sep; 33(9):1539-45. PubMed ID: 17720067
[TBL] [Abstract][Full Text] [Related]
34. Endocan Blockade Suppresses Experimental Ocular Neovascularization in Mice.
Su T; Zhong Y; Demetriades AM; Shen J; Sui A; Yao Y; Gao Y; Zhu Y; Shen X; Xie B
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):930-939. PubMed ID: 29450540
[TBL] [Abstract][Full Text] [Related]
35. Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression.
Liu NN; Sun YZ; Zhao N; Chen L
Clin Exp Ophthalmol; 2015 Jul; 43(5):458-65. PubMed ID: 25472856
[TBL] [Abstract][Full Text] [Related]
36. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.
Gamache DA; Graff G; Brady MT; Spellman JM; Yanni JM
Inflammation; 2000 Aug; 24(4):357-70. PubMed ID: 10850857
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
[TBL] [Abstract][Full Text] [Related]
38. A peptide encoded by exon 6 of VEGF (EG3306) inhibits VEGF-induced angiogenesis in vitro and ischaemic retinal neovascularisation in vivo.
Bainbridge JW; Jia H; Bagherzadeh A; Selwood D; Ali RR; Zachary I
Biochem Biophys Res Commun; 2003 Mar; 302(4):793-9. PubMed ID: 12646239
[TBL] [Abstract][Full Text] [Related]
39. RPE cells modulate subretinal neovascularization, but do not cause regression in mice with sustained expression of VEGF.
Ida H; Tobe T; Nambu H; Matsumura M; Uyama M; Campochiaro PA
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5430-7. PubMed ID: 14638748
[TBL] [Abstract][Full Text] [Related]
40. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.
Ishida S; Usui T; Yamashiro K; Kaji Y; Amano S; Ogura Y; Hida T; Oguchi Y; Ambati J; Miller JW; Gragoudas ES; Ng YS; D'Amore PA; Shima DT; Adamis AP
J Exp Med; 2003 Aug; 198(3):483-9. PubMed ID: 12900522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
